GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vivozon Pharmaceutical Co Ltd (XKRX:082800) » Definitions » Ending Cash Position

Vivozon Pharmaceutical Co (XKRX:082800) Ending Cash Position : ₩3,401 Mil (As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Vivozon Pharmaceutical Co Ending Cash Position?

Vivozon Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ₩3,401 Mil.

Vivozon Pharmaceutical Co's quarterly Ending Cash Position increased from Sep. 2023 (₩3,666 Mil) to Dec. 2023 (₩7,987 Mil) but then declined from Dec. 2023 (₩7,987 Mil) to Mar. 2024 (₩3,401 Mil).

Vivozon Pharmaceutical Co's annual Ending Cash Position declined from Dec. 2021 (₩13,799 Mil) to Dec. 2022 (₩2,351 Mil) but then increased from Dec. 2022 (₩2,351 Mil) to Dec. 2023 (₩7,987 Mil).

Vivozon Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for Vivozon Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivozon Pharmaceutical Co Ending Cash Position Chart

Vivozon Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 57,330.92 64,331.22 13,798.68 2,351.14 7,986.51

Vivozon Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,866.53 5,373.12 3,666.02 7,986.51 3,400.95

Vivozon Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Vivozon Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=2351.141+5635.365
=7,987

Vivozon Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=7986.507+-4585.558
=3,401

Vivozon Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Vivozon Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Vivozon Pharmaceutical Co (XKRX:082800) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vivozon Pharmaceutical Co Ltd (XKRX:082800) » Definitions » Ending Cash Position
Comparable Companies
XKRX:002390 XKRX:023910 XKRX:214390 XKRX:176750 XKRX:002620 XKRX:293780 XKRX:067080 XKRX:001360 XKRX:011040 XKRX:061250 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Yongin Techno Valley, 9th and 10th Floor, Building D, Guseong-ro 357, Giheung-gu, Gyeonggi-do, Yongin-si, KOR
Website
http://www.lummimicro.com
Vivozon Pharmaceutical Co Ltd is a global innovative drug development company.

Vivozon Pharmaceutical Co (XKRX:082800) Headlines

No Headlines